Preconvulsive changes in brain glucose metabolism following drugs inhibiting glutamate decarboxylase.
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001831:Body Temperature / Q000187:drug effects; D001921:Brain / Q000378:metabolism*; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D005947:Glucose / Q000378:metabolism*; D005968:Glutamate Decarboxylase / Q000037:antagonists & inhibitors*; D005998:Glycine / Q000031:analogs & derivatives / Q000494:pharmacology; D006003:Glycogen / Q000378:metabolism; D007538:Isoniazid / Q000494:pharmacology; D008297:Male; D008717:Methionine Sulfoximine / Q000494:pharmacology; D051379:Mice; D011736:Pyridoxine / Q000031:analogs & derivatives; D012640:Seizures / Q000139:chemically induced / Q000378:metabolism*; D013997:Time Factors
D001786:Blood Glucose; D008717:Methionine Sulfoximine; D006003:Glycogen; D002262:Carboxy-Lyases; D005968:Glutamate Decarboxylase; D005947:Glucose; D011736:Pyridoxine; D005998:Glycine; D007538:Isoniazid